Literature DB >> 1466842

Vertical transmission of HIV-1: lack of detectable virus in peripheral blood cells of infected children at birth.

A De Rossi1, L Ometto, F Mammano, C Zanotto, C Giaquinto, L Chieco-Bianchi.   

Abstract

OBJECTIVE: To evaluate the time-course of HIV-1 detection in peripheral blood mononuclear cells (PBMC) from newborns at risk of vertically acquired infection. DESIGN AND
METHOD: Forty-six infants born to HIV-1-infected mothers were enrolled at birth and examined virologically and clinically in the perinatal period and every 30 days for the first 3 months of life. Follow-up was conducted at intervals of 2-3 months. HIV-1 detection in PBMC was performed using virus culture and polymerase chain reaction (PCR) assay.
RESULTS: Only one out of 24 newborns tested within 48 h of delivery and two out of 22 infants tested between 3 and 15 days of age were found to be HIV-1-positive by both PCR and virus culture. Further testing performed between 30 and 60 days of life identified an additional eight HIV-1-positive children. Subsequent viral, immunological and clinical follow-up confirmed PCR and virus culture results obtained in 30-60-day-old children.
CONCLUSIONS: Infected infants had detectable levels of HIV-1 in their PBMC at 1 month of age. The negative PCR and virus culture findings in PBMC of newborns indicate strongly that HIV-1 cannot be diagnosed at birth in the majority of cases, and suggests that viral transmission could occur during late pregnancy and/or delivery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466842

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

Review 1.  Epidemiology and prevention of AIDS in children.

Authors:  J P Narain; G Sodhi
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

2.  HIV-1 Transmission, Replication Fitness and Disease Progression.

Authors:  Tasha Biesinger; Jason T Kimata
Journal:  Virology (Auckl)       Date:  2008-07-14

3.  High prevalence of Borna disease virus infection in healthy sheep in Japan.

Authors:  K Hagiwara; S Kawamoto; H Takahashi; Y Nakamura; T Nakaya; T Hiramune; C Ishihara; K Ikuta
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

4.  Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease.

Authors:  F Salvatori; S Masiero; C Giaquinto; C M Wade; A J Brown; L Chieco-Bianchi; A De Rossi
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin.

Authors:  S Lee-Huang; P L Huang; Y Sun; P L Huang; H F Kung; D L Blithe; H C Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories.

Authors:  J B Jackson; J Drew; H J Lin; P Otto; J W Bremer; F B Hollinger; S M Wolinsky
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Effective use of frozen donor peripheral blood mononuclear cells for human immunodeficiency virus type 1 isolation from vertically infected pediatric patients.

Authors:  M O Paul; S Tetali; S Pahwa
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

9.  Detection of HIV-1 proviral sequences in lymphocytes using a qualitative polymerase chain reaction assay.

Authors:  M G Marin; F Lillo; O E Varnier; S Bresciani; A Molinelli; C Abecasis; P A Bonini; A Albertini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

10.  Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection.

Authors:  A De Rossi; S Masiero; C Giaquinto; E Ruga; M Comar; M Giacca; L Chieco-Bianchi
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.